Dr. Rizvi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Dudley St
Ste 555
Providence, RI 02905Phone+1 401-444-3799Fax+1 401-444-2838
Education & Training
Stony Brook Medicine/University HospitalResidency, Neurology, 1998 - 1999- Stony Brook Medicine/University HospitalResidency, Internal Medicine, 1994 - 1998
- Stony Brook Medicine/University HospitalResidency, Neurology, 1994 - 1997
- Stony Brook Medicine/University HospitalResidency, Neurology, 1993 - 1994
AtlantiCare Regional Medical CenterInternship, Internal Medicine, 1992 - 1993
Dow University of Health SciencesClass of 1991
Certifications & Licensure
RI State Medical License 2001 - 2026
NY State Medical License 1999 - 2002
PA State Medical License 1993 - 1994- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
Clinical Trials
- Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis Start of enrollment: 2011 Mar 01
Publications & Presentations
PubMed
- Varicella Zoster Associated Vasculopathy and Retinitis with Natalizumab Use in Multiple Sclerosis.Erika L Thayer, Syed A Rizvi, Glenn A Tung
Rhode Island Medical Journal. 2024-01-04 - 5 citationsAggressive MOGAD with bilateral corticospinal tract lesions following infection with Jamestown Canyon virus.Alexander M Abud, Syed Rizvi, Hadeel Zainah, Thomas C O'Brien, Mauricio F Villamar
Journal of Neuroimmunology. 2022-12-15 - 3 citationsThe Lived Experiences of Adults with Multiple Sclerosis.Kayla K Haubrick, Emily A Gadbois, Susan E. Campbell, Jessica Young, Tingting Zhang
Rhode Island Medical Journal. 2021-08-02
Press Mentions
Dr. Rizvi on Treatment Considerations in Stage III/IV Hodgkin LymphomaFebruary 11th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
